Literature DB >> 84130

Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III.

G W Fischer, G H Lowell, M H Crumrine, S R Wilson.   

Abstract

Antisera directed against type-14 pneumococcus was opsonic for several strains of type-III group-B streptococcus. Furthermore, the polysaccharide antigen in the polyvalent pneumococcal vaccine reacted to form precipitation lines with antisera directed against type-14 pneumococcus and group-B streptococcus type III Immunisation with currently available pneumococcal vaccine may provide opsonic antibody against group-B streptococci and provide a method of preventing neonatal group-B streptococcal infections.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 84130     DOI： 10.1016/s0140-6736(79)90064-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  4 in total

Review 1.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

2.  Indirect sandwich enzyme-linked immunosorbent assay for rapid detection of Streptococcus pneumoniae type 3 antigen.

Authors:  D L Drow; D D Manning
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

3.  Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.

Authors:  Hilde-Kari Guttormsen; Carol J Baker; Moon H Nahm; Lawrence C Paoletti; Susu M Zughaier; Morven S Edwards; Dennis L Kasper
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Detection of group B streptococcal antigen in early-onset and late-onset group B streptococcal disease with the Wellcogen Strep B latex agglutination test.

Authors:  D L Ingram; D M Suggs; A W Pearson
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.